Patent · US Active

Inhibitors of RET

US10584114B2 · kind B2 · utility

11Cited by
26References
3Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 20, 2018
Grant dateMar 10, 2020
Priority date—
Expiry dateJul 20, 2038

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D403/14
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

Described herein are compounds that inhibit wild-type RET and its resistant mutants, pharmaceutical compositions including such compounds, and methods of using such compounds and compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.